Dr. Premavathy Krishnarao is a highly experienced professional in the field of pharmacovigilance, currently serving as Senior Director at Mineralys Therapeutics, Inc. Previous roles include Global Safety Lead at SGS-Biogen, Head of Pharmacovigilance at Luitpold Pharmaceuticals, and Head of PV (Immuno-oncology) at Immunomedics (now Gilead). Additionally, Dr. Krishnarao held the position of Medical Director of Pharmacovigilance at Pearl Therapeutics. This extensive background reflects a strong expertise in ensuring drug safety and regulatory compliance.